Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

LY 235959

LY 235959 is a competitive N-methyl-D-aspartate (NMDA) -receptor antagonist. LY 235959 potentiates the anticonvulsant action of antiepileptics[1].

Product Specifications

CAS Number

137433-06-8

Product Name Alternative

(-) -LY 235959

UNSPSC

12352005

Hazard Statement

H302-H315-H319-H335

Target

IGluR

Type

Reference compound

Related Pathways

Membrane Transporter/Ion Channel; Neuronal Signaling

Applications

Neuroscience-Neurodegeneration

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/ly-235959.html

Solubility

10 mM in DMSO

Smiles

OC([C@@H]1C[C@]2([H])[C@@](CN1)([H])CC[C@@H](C2)CP(O)(O)=O)=O

Molecular Formula

C11H20NO5P

Molecular Weight

277.25

Precautions

P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

References & Citations

[1]K K Borowicz, et al. Competitive NMDA-receptor antagonists, LY 235959 and LY 233053, enhance the protective efficacy of various antiepileptic drugs against maximal electroshock-induced seizures in mice. Epilepsia. 1996 Jul;37 (7) :618-24.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Ozenoxacin-d3
TMIH-0418-01 1 mg

Ozenoxacin-d3

Sign In for Pricing
View Details
Ozenoxacin-d3
TMIH-0418-02 5 mg

Ozenoxacin-d3

Sign In for Pricing
View Details
Ozenoxacin-d3
TMIH-0418-03 10 mg

Ozenoxacin-d3

Sign In for Pricing
View Details
Ozenoxacin-d3
TMIH-0418-04 25 mg

Ozenoxacin-d3

Sign In for Pricing
View Details
MAP2K7 Antibody, FITC conjugated
CSB-PA013416LC01HU-01 50 µg

MAP2K7 Antibody, FITC conjugated

Sign In for Pricing
View Details
MAP2K7 Antibody, FITC conjugated
CSB-PA013416LC01HU-02 100 µg

MAP2K7 Antibody, FITC conjugated

Sign In for Pricing
View Details